TY - JOUR
T1 - Conformational free energy landscape of a glutamate transporter and microscopic details of its transport mechanism
AU - Thangapandian, Sundar
AU - Fakharzadeh, Ashkan
AU - Moradi, Mahmoud
AU - Tajkhorshid, Emad
N1 - This research used resources of the Oak Ridge Leadership Computing Facility, which is a U. S. Department of Energy Office of Science User Facility supported under Contract DE-AC05-00OR22725 and the Blue Waters sustained-petascale computing project\u2014which is supported by the NSF (award number ACI 1238993) and the state of Illinois. This research is supported by NIH grants U54-GM087519, R01-GM123455, P41-GM104601, R24-GM145965, R35-GM147423, and R15-GM139140 and NSF grant CHE 1945465.
PY - 2025/3/11
Y1 - 2025/3/11
N2 - Removing glutamate from the synaptic cleft is vital for proper function of the brain. Excitatory amino acid transporters mediate this process by uptaking the neurotransmitter from the synaptic cleft back to the cell after its release. The archaeal homolog, GltPh, an aspartate transporter from Pyrococcus horikoshii, presents the best structurally characterized model for this family of transporters. In order to transport, GltPh undergoes elevator-like conformational changes between inward-facing (IF) and outward-facing (OF) states. Here, we characterize, at an atomic level, the OF⇔IF transition of GltPh in different apo/bound states using a combination of ensemble-based enhanced sampling techniques, employing more than two thousand of coupled simulation replicas of membrane-embedded GltPh. The resulting free-energy profiles portray the transition of apo/bound states as a complex four-stage process, while sodium binding alone locks the structure in one of its states. Along the transition, the transport domain (TD) disengages from the scaffold domain (SD), allowing it to move as a piston sliding vertically with respect to the membrane during the elevator-like motion of TD. Lipid interactions with residues comprising the SD–TD interface directly influence the large-scale conformational changes and, consequently, the energetics of transport. Structural intermediates formed during the transition leak water molecules and may correlate to the uncoupled Cl− ion conductance observed experimentally in both prokaryotic and mammalian glutamate transporters. Mechanistic insights obtained from our study provide a structural framework for better development of therapeutic for neurological disorders.
AB - Removing glutamate from the synaptic cleft is vital for proper function of the brain. Excitatory amino acid transporters mediate this process by uptaking the neurotransmitter from the synaptic cleft back to the cell after its release. The archaeal homolog, GltPh, an aspartate transporter from Pyrococcus horikoshii, presents the best structurally characterized model for this family of transporters. In order to transport, GltPh undergoes elevator-like conformational changes between inward-facing (IF) and outward-facing (OF) states. Here, we characterize, at an atomic level, the OF⇔IF transition of GltPh in different apo/bound states using a combination of ensemble-based enhanced sampling techniques, employing more than two thousand of coupled simulation replicas of membrane-embedded GltPh. The resulting free-energy profiles portray the transition of apo/bound states as a complex four-stage process, while sodium binding alone locks the structure in one of its states. Along the transition, the transport domain (TD) disengages from the scaffold domain (SD), allowing it to move as a piston sliding vertically with respect to the membrane during the elevator-like motion of TD. Lipid interactions with residues comprising the SD–TD interface directly influence the large-scale conformational changes and, consequently, the energetics of transport. Structural intermediates formed during the transition leak water molecules and may correlate to the uncoupled Cl− ion conductance observed experimentally in both prokaryotic and mammalian glutamate transporters. Mechanistic insights obtained from our study provide a structural framework for better development of therapeutic for neurological disorders.
KW - enhanced sampling
KW - free energy
KW - membrane transporter
KW - molecular dynamics
UR - http://www.scopus.com/inward/record.url?scp=86000515851&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=86000515851&partnerID=8YFLogxK
U2 - 10.1073/pnas.2416381122
DO - 10.1073/pnas.2416381122
M3 - Article
C2 - 40042900
AN - SCOPUS:86000515851
SN - 0027-8424
VL - 122
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 10
M1 - e2416381122
ER -